PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Statistics

Total Valuation

PTCT has a market cap or net worth of $3.27 billion. The enterprise value is $4.66 billion.

Market Cap	3.27B
Enterprise Value	4.66B

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

PTCT has 76.92 million shares outstanding. The number of shares has increased by 3.87% in one year.

Shares Outstanding	76.92M
Shares Change (YoY)	+3.87%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	2.32%
Owned by Institutions (%)	86.84%
Float	60.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.59
Forward PS	5.07
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.17
EV / EBITDA	366.10
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.23

Current Ratio	2.23
Quick Ratio	2.10
Debt / Equity	n/a
Debt / EBITDA	60.53
Debt / FCF	n/a
Interest Coverage	-1.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-7.39%
Return on Capital (ROIC)	-10.06%
Revenue Per Employee	$853,511
Profits Per Employee	-$454,518
Employee Count	1,055
Asset Turnover	0.55
Inventory Turnover	18.88

Taxes

Income Tax	-14.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +129.61% in the last 52 weeks. The beta is 0.65, so PTCT's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+129.61%
50-Day Moving Average	36.29
200-Day Moving Average	32.24
Relative Strength Index (RSI)	64.54
Average Volume (20 Days)	823,717

Short Selling Information

The latest short interest is 4.66 million, so 6.06% of the outstanding shares have been sold short.

Short Interest	4.66M
Short Previous Month	4.27M
Short % of Shares Out	6.06%
Short % of Float	7.66%
Short Ratio (days to cover)	5.65

Income Statement

In the last 12 months, PTCT had revenue of $900.45 million and -$479.52 million in losses. Loss per share was -$6.31.

Revenue	900.45M
Gross Profit	297.71M
Operating Income	-192.45M
Pretax Income	-494.07M
Net Income	-479.52M
EBITDA	12.72M
EBIT	-192.45M
Loss Per Share	-$6.31

Balance Sheet

The company has $1.09 billion in cash and $2.48 billion in debt, giving a net cash position of -$1.39 billion or -$18.03 per share.

Cash & Cash Equivalents	1.09B
Total Debt	2.48B
Net Cash	-1.39B
Net Cash Per Share	-$18.03
Equity (Book Value)	-980.18M
Book Value Per Share	-12.75
Working Capital	748.11M

Cash Flow

In the last 12 months, operating cash flow was -$115.50 million and capital expenditures -$14.14 million, giving a free cash flow of -$129.64 million.

Operating Cash Flow	-115.50M
Capital Expenditures	-14.14M
Free Cash Flow	-129.64M
FCF Per Share	-$1.69

Margins

Gross margin is 33.06%, with operating and profit margins of -21.37% and -53.25%.

Gross Margin	33.06%
Operating Margin	-21.37%
Pretax Margin	-54.87%
Profit Margin	-53.25%
EBITDA Margin	1.41%
EBIT Margin	-21.37%
FCF Margin	-11.28%

Dividends & Yields

PTCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.87%
Shareholder Yield	-3.87%
Earnings Yield	-14.67%
FCF Yield	-3.97%

Analyst Forecast

The average price target for PTCT is $38.54, which is -9.32% lower than the current price. The consensus rating is "Hold".

Price Target	$38.54
Price Target Difference	-9.32%
Analyst Consensus	Hold
Analyst Count	13
Revenue Growth Forecast (5Y)	6.99%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PTCT has an Altman Z-Score of -1.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.46
Piotroski F-Score	4